Connection

Edwin Smith to Adult

This is a "connection" page, showing publications Edwin Smith has written about Adult.
Connection Strength

0.101
  1. Monoamniotic twin discordant for bilateral renal agenesis with normal pulmonary function. Urology. 2004 Sep; 64(3):589.
    View in: PubMed
    Score: 0.017
  2. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol. 2013 Nov; 40(11):1812-22.
    View in: PubMed
    Score: 0.008
  3. Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans. Arthritis Rheum. 2010 Dec; 62(12):3547-53.
    View in: PubMed
    Score: 0.007
  4. A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis. Arthritis Rheum. 2010 Oct; 62(10):2864-75.
    View in: PubMed
    Score: 0.006
  5. Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2010 Aug; 62(8):2219-26.
    View in: PubMed
    Score: 0.006
  6. Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther. 2010; 12(3):R75.
    View in: PubMed
    Score: 0.006
  7. Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study. Arthritis Care Res (Hoboken). 2010 May; 62(5):624-31.
    View in: PubMed
    Score: 0.006
  8. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol. 2010 Feb; 37(2):275-81.
    View in: PubMed
    Score: 0.006
  9. An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. PLoS Genet. 2009 Mar; 5(3):e1000424.
    View in: PubMed
    Score: 0.006
  10. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease. Arthritis Rheum. 2008 Jun; 58(6):1810-22.
    View in: PubMed
    Score: 0.006
  11. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum. 2008 Feb; 58(2):349-58.
    View in: PubMed
    Score: 0.005
  12. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8.
    View in: PubMed
    Score: 0.005
  13. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol. 2007 Jun; 34(6):1277-82.
    View in: PubMed
    Score: 0.005
  14. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Arthritis Rheum. 2004 May; 50(5):1566-77.
    View in: PubMed
    Score: 0.004
  15. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J Invest Dermatol. 2002 Apr; 118(4):704-11.
    View in: PubMed
    Score: 0.004
  16. Metabolic risk factors for stone formation in patients with cystic fibrosis. J Urol. 2002 Feb; 167(2 Pt 1):480-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.